RedShift BioAnalytics Company
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind.
The company was founded in 2005 and is headquartered in Burlington, Massachusetts.
Total Funding:
76663992
Founded Date:
2005-01-01
Industry:
Quantum Chemistry
Employee Number:
11-50
Last Funding Date:
2025-06-25
Funding Status:
private
Headquarters:
Burlington,Massachusetts,United States,North America
Super Industry:
Quantum Science Applications
Funding Total Value:
76663992
Last Funding Total Usd:
5914304
Last Funding Total Currency:
USD
Last Funding Total Value:
5914304
Founders:
Chip Marshall,Eugene Ma,Matthias Wagner,Stuart Nixdorff
Phone Number:
781.345.7300